Reuters: Health News: AbbVie’s Skyrizi drug to treat psoriasis wins U.S. approval

AbbVie Inc said on Tuesday that the U.S. Food and Drug Administration approved its Skyrizi drug as a treatment for plaque psoriasis at a time when its blockbuster psoriasis drug, Humira, faces patent pressures.

Reuters: Health News